Low dose colchicine gets FDA approval for secondary prevention of heart disease

by

Colchicine, a widely available gout medication, has received FDA approval to be used in low dose to prevent cardiovascular events in patients with proven coronary disease.

Leave A Comment

Your email address will not be published. Required fields are marked *